A Prospective, Randomized, Open-Label Study to Evaluate the Immune Responses of Trivalent Cold-Adapted Influenza Vaccine (CAIV-T) Compared With Trivalent Inactivated Vaccine (TIV) in Children 6 to <36 Months of Age
Phase of Trial: Phase II
Latest Information Update: 23 Jul 2008
At a glance
- Drugs Influenza virus vaccine; Influenza virus vaccine live
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 23 Jul 2008 Status changed from in progress to completed, as reported by ClinicalTrials.gov.
- 12 Oct 2005 New trial record.